 |
Pilomyxoid Astrocytoma: A Review CME Authors: Ricardo J. Komotar, MD; J Mocco, MD; Benjamin S. Carson, MD; Michael E. Sughrue, BS; Brad E. Zacharia, BS; Alexander C. Sisti; Peter D. Canoll, MD, PhD; Alexander G. Khandji, MD; Tarik Tihan, MD, PhD; Peter C. Burger, MD; Jeffrey N. Bruce, MDDisclosuresRelease Date: November 24, 2004; Valid for credit through November 24, 2005 This activity has expired. CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities. |
| Contents of This CME Activity | |
| Pilomyxoid astrocytoma (PMA) is an emerging diagnosis with important implications for pediatric neurooncology. Pediatric oncologists and neurosurgeons need to be aware of how PMA differs in terms of its natural history, pathology, and radiographic findings from pilocytic astrocytoma. This article addresses these issues and anticipates future investigations of PMA. - Pilomyxoid Astrocytoma: A Review
Ricardo J. Komotar, MD
J Mocco, MD
Benjamin S. Carson, MD
Michael E. Sughrue, BS
Brad E. Zacharia, BS
Alexander C. Sisti
Peter D. Canoll, MD, PhD
Alexander G. Khandji, MD
Tarik Tihan, MD, PhD
Peter C. Burger, MD
Jeffrey N. Bruce, MD
|
| Legal Disclaimer | |
| The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2004 Medscape. |
|
|
 |
Medscape is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape designates this educational activity for a maximum of 0.5 category 1 credit(s) toward the AMA Physician's Recognition Award. Each physician should claim only those credits that reflect the time he/she actually spent in the activity.
Contact This Provider
|
|
